Amid an unusually early and intense flu surge across the UK, health officials urge parents to prioritise the nasal spray vaccine for children to prevent severe illness and hospitalisations.
As the 2025/26 flu season intensifies with an unusually early and sharp rise in cases across the UK, leading paediatricians and health officials have made a renewed plea for parents to ensure their children receive the flu vaccine. The Royal College of Paediatrics and Child Health (RCPCH) has urged parents to prioritise the nasal spray flu vaccine for their children, citing concerns over the impact of this season’s particularly severe flu activity.
Data from the UK Health Security Agency (UKHSA) indicates that the current flu vaccine offers robust protection, with around 70-75% effectiveness in preventing hospital attendance among children aged two to seventeen. Adults also benefit, with vaccine effectiveness estimated at 30-40%, despite the flu season being driven by a new “drifted” influenza A(H3N2) subclade K strain dominating cases, especially in England. This strain has contributed to an earlier onset of the flu season, with hospital admissions rising significantly, particularly among younger children. NHS England has highlighted that flu cases are already three times higher than at the same point last year, prompting urgent calls for vaccination ahead of the winter peak.
Dr Helen Stewart, RCPCH officer for health improvement, emphasised the importance of vaccination to prevent serious illness, noting that flu can strike down previously healthy children as well as those with underlying conditions. She warned that flu is not just a “bad cold,” pointing out the risk of severe complications such as pneumonia and sepsis that can necessitate intensive care. Tragically, she reminded that children do die from flu every year. Dr Stewart also highlighted the challenge for parents to return consent forms for school-based vaccination programmes, encouraging vigilance to avoid missing opportunities to protect young children.
RCPCH has developed an information sheet aimed at parents to dispel common misconceptions and clearly explain the benefits and safety of the flu vaccine for kids. Complementing this, Dr Andrew Whittamore, clinical lead at Asthma and Lung UK, stressed the vital need for children with lung conditions, including asthma, to be vaccinated promptly alongside other recommended winter immunisations.
The NHS has been proactive in expanding flu vaccine access, simplifying the process for toddlers by making vaccines available at local pharmacies and supermarkets, thereby enhancing convenience for families. This follows broader NHS efforts, including a recent ‘flu jab SOS’ campaign that opened 2.4 million vaccination slots nationwide to curb the surge in cases and protect vulnerable populations during the coming months.
The importance of these efforts is underscored by UKHSA data from the 2024/25 flu season, which showed the flu vaccine prevented approximately 96,000 to 120,000 hospitalisations in England alone. However, despite these clear benefits, vaccine uptake, especially among children, has declined in recent years, prompting health experts to call for renewed focus on immunisation rates.
Looking ahead, the Joint Committee on Vaccination and Immunisation (JCVI) has responded to the high burden of disease and increased paediatric deaths observed last season by recommending changes in the vaccination schedule. They propose shifting the start of the adult flu vaccination programme from September to October to better align with peak flu activity, aiming to optimise protection.
Public health officials continually reaffirm that vaccination remains the most effective defence against flu’s potentially severe outcomes. Alongside flu vaccines, good respiratory hygiene practices remain critical as flu activity continues to rise unusually early and rapidly. Protecting children through vaccination not only safeguards their health but also helps shield more vulnerable populations, including elderly relatives and those with chronic conditions, by limiting the spread of infection.
📌 Reference Map:
- [1] (Irish News) – Paragraphs 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- [2] (Gov.uk) – Paragraphs 2, 11
- [3] (Gov.uk) – Paragraphs 12, 13
- [4] (NHS England) – Paragraph 14, 15
- [5] (NHS England) – Paragraph 15
- [6] (Gov.uk JCVI) – Paragraph 16
- [7] (Gov.uk) – Paragraphs 12, 13
Source: Noah Wire Services
Noah Fact Check Pro
The draft above was created using the information available at the time the story first
emerged. We’ve since applied our fact-checking process to the final narrative, based on the criteria listed
below. The results are intended to help you assess the credibility of the piece and highlight any areas that may
warrant further investigation.
Freshness check
Score:
8
Notes:
The narrative is recent, published on 12 November 2025. The earliest known publication date of similar content is 11 November 2025, with the UK Health Security Agency’s announcement on vaccine effectiveness. ([gov.uk](https://www.gov.uk/government/news/flu-vaccine-providing-important-protection-despite-new-subclade?utm_source=openai)) The report is based on a press release from the UKHSA, which typically warrants a high freshness score. No discrepancies in figures, dates, or quotes were found. No earlier versions show different information.
Quotes check
Score:
9
Notes:
The quotes from Dr Helen Stewart and Dr Andrew Whittamore are unique to this narrative. No identical quotes appear in earlier material. No variations in wording were found. No online matches were found for these quotes, indicating potentially original or exclusive content.
Source reliability
Score:
8
Notes:
The narrative originates from The Irish News, a reputable organisation. The UKHSA, a government agency, is cited as the source of the information. The Royal College of Paediatrics and Child Health (RCPCH) and Asthma and Lung UK are also mentioned, both of which are established organisations.
Plausability check
Score:
9
Notes:
The claims about the flu vaccine’s effectiveness and the early onset of the flu season are consistent with recent data from the UKHSA. The narrative aligns with the UK’s public health messaging. The language and tone are appropriate for the topic and region. No excessive or off-topic details are present. The tone is consistent with typical corporate or official language.
Overall assessment
Verdict (FAIL, OPEN, PASS): PASS
Confidence (LOW, MEDIUM, HIGH): HIGH
Summary:
The narrative is recent and based on a press release from the UKHSA, ensuring high freshness. The quotes are unique and not found elsewhere, indicating originality. The sources are reputable, and the claims are consistent with recent data, enhancing credibility. The language and tone are appropriate, with no signs of disinformation.
